179 related articles for article (PubMed ID: 29528635)
1. Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
Que NLS; Crowley VM; Duerfeldt AS; Zhao J; Kent CN; Blagg BSJ; Gewirth DT
J Med Chem; 2018 Apr; 61(7):2793-2805. PubMed ID: 29528635
[TBL] [Abstract][Full Text] [Related]
2. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design.
Immormino RM; Metzger LE; Reardon PN; Dollins DE; Blagg BS; Gewirth DT
J Mol Biol; 2009 May; 388(5):1033-42. PubMed ID: 19361515
[TBL] [Abstract][Full Text] [Related]
3. Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone.
Immormino RM; Dollins DE; Shaffer PL; Soldano KL; Walker MA; Gewirth DT
J Biol Chem; 2004 Oct; 279(44):46162-71. PubMed ID: 15292259
[TBL] [Abstract][Full Text] [Related]
4. Structure of unliganded GRP94, the endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational change.
Dollins DE; Immormino RM; Gewirth DT
J Biol Chem; 2005 Aug; 280(34):30438-47. PubMed ID: 15951571
[TBL] [Abstract][Full Text] [Related]
5. Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones.
Dollins DE; Warren JJ; Immormino RM; Gewirth DT
Mol Cell; 2007 Oct; 28(1):41-56. PubMed ID: 17936703
[TBL] [Abstract][Full Text] [Related]
6. The ATPase cycle of the endoplasmic chaperone Grp94.
Frey S; Leskovar A; Reinstein J; Buchner J
J Biol Chem; 2007 Dec; 282(49):35612-20. PubMed ID: 17925398
[TBL] [Abstract][Full Text] [Related]
7. NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90.
Huck JD; Que NLS; Immormino RM; Shrestha L; Taldone T; Chiosis G; Gewirth DT
J Biol Chem; 2019 Nov; 294(44):16010-16019. PubMed ID: 31501246
[TBL] [Abstract][Full Text] [Related]
8. Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.
Soldano KL; Jivan A; Nicchitta CV; Gewirth DT
J Biol Chem; 2003 Nov; 278(48):48330-8. PubMed ID: 12970348
[TBL] [Abstract][Full Text] [Related]
9. Adenosine nucleotides and the regulation of GRP94-client protein interactions.
Rosser MF; Trotta BM; Marshall MR; Berwin B; Nicchitta CV
Biochemistry; 2004 Jul; 43(27):8835-45. PubMed ID: 15236592
[TBL] [Abstract][Full Text] [Related]
10. Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94.
Wearsch PA; Voglino L; Nicchitta CV
Biochemistry; 1998 Apr; 37(16):5709-19. PubMed ID: 9548957
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of hsp90 paralogs: Structure and binding studies uncover the role of helix 1 in Grp94-selective ligand binding.
Que NLS; Seidler PM; Aw WJ; Chiosis G; Gewirth DT
bioRxiv; 2023 Aug; ():. PubMed ID: 37577523
[TBL] [Abstract][Full Text] [Related]
12. Development of a Grp94 inhibitor.
Duerfeldt AS; Peterson LB; Maynard JC; Ng CL; Eletto D; Ostrovsky O; Shinogle HE; Moore DS; Argon Y; Nicchitta CV; Blagg BS
J Am Chem Soc; 2012 Jun; 134(23):9796-804. PubMed ID: 22642269
[TBL] [Abstract][Full Text] [Related]
13. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity.
Wassenberg JJ; Reed RC; Nicchitta CV
J Biol Chem; 2000 Jul; 275(30):22806-14. PubMed ID: 10816560
[TBL] [Abstract][Full Text] [Related]
14. Grp94, the endoplasmic reticulum Hsp90, has a similar solution conformation to cytosolic Hsp90 in the absence of nucleotide.
Krukenberg KA; Böttcher UM; Southworth DR; Agard DA
Protein Sci; 2009 Sep; 18(9):1815-27. PubMed ID: 19554567
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Functional Complementation between Grp94 and Hsp90.
Maharaj KA; Que NL; Hong F; Huck JD; Gill SK; Wu S; Li Z; Gewirth DT
PLoS One; 2016; 11(11):e0166271. PubMed ID: 27824935
[TBL] [Abstract][Full Text] [Related]
16. A Grp on the Hsp90 mechanism.
Richter K; Reinstein J; Buchner J
Mol Cell; 2007 Oct; 28(2):177-9. PubMed ID: 17964255
[TBL] [Abstract][Full Text] [Related]
17. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis.
Jiang F; Guo AP; Xu JC; You QD; Xu XL
J Med Chem; 2018 Nov; 61(21):9513-9533. PubMed ID: 30351001
[TBL] [Abstract][Full Text] [Related]
19. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding.
Rosser MF; Nicchitta CV
J Biol Chem; 2000 Jul; 275(30):22798-805. PubMed ID: 10816561
[TBL] [Abstract][Full Text] [Related]
20. Development of radamide analogs as Grp94 inhibitors.
Muth A; Crowley V; Khandelwal A; Mishra S; Zhao J; Hall J; Blagg BS
Bioorg Med Chem; 2014 Aug; 22(15):4083-98. PubMed ID: 25027801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
